Long-Term Outcome of Ciclosporin and Infliximab as Rescue Therapy in Steroid-Refractory Acute Severe Ulcerative Colitis
This real-world single-center analysis confirms the equal efficacy and safety of infliximab and ciclosporin over a follow-up of 5 years. Patients not responding to the first may benefit of a second rescue therapy without increasing the risk of complication or mortality.
Authors
- Philipp Schreiner (ORCID: https://orcid.org/0000-0003-1610-1925)
- Luc Biedermann (ORCID: https://orcid.org/0000-0003-0824-4125)
- Gerhard Rogler (ORCID: https://orcid.org/0000-0002-1733-9188)
- Gottfried Novacek (ORCID: https://orcid.org/0000-0002-0869-0478)
- Andrea Kreienbühl (ORCID: https://orcid.org/0009-0002-3564-639X)
- Florian Groβ
- Isabel Häberling
Institutions
- University of Zurich (CH)
- University Hospital of Zurich (CH)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Inflammatory Intestinal Diseases
- Published
- 2025-05-26
- DOI
- https://doi.org/10.1159/000546511
- Citations
- 1
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 1.82